160 related articles for article (PubMed ID: 2523585)
1. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
Copeland KR; Yatscoff RW; Rush D; Jeffery JR
Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
[No Abstract] [Full Text] [Related]
2. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
Freed BM; Rosano TG; Quick C; Lempert N
Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
[No Abstract] [Full Text] [Related]
3. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
Woo J; Sewell HF; Thomson AW
Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
[No Abstract] [Full Text] [Related]
4. In vitro immunosuppressive effect of deoxymethylspergualin.
Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
[No Abstract] [Full Text] [Related]
5. Immunosuppressive activity of cyclosporine metabolites in vitro.
Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
[No Abstract] [Full Text] [Related]
6. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients.
Tufveson G; Odlind B; Sjöberg O; Lindberg A; Gabrielsson J; Lindström B; Lithell H; Selinus I; Tötterman T; Wahlberg J
Transplant Proc; 1986 Dec; 18(6 Suppl 5):16-24. PubMed ID: 2947364
[No Abstract] [Full Text] [Related]
7. Cyclosporin A.
Morris PJ
Transplantation; 1981 Nov; 32(5):349-54. PubMed ID: 6460358
[No Abstract] [Full Text] [Related]
8. Lymphocyte activation mechanisms and in vitro actions of immunosuppressive drugs: a comparison.
Dupont E; Denys C; Schandene L; Pereleux A; Romasco F; Wybran J
Transplant Proc; 1987 Feb; 19(1 Pt 2):1227-9. PubMed ID: 3152625
[No Abstract] [Full Text] [Related]
9. Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses.
Bowes LG; Dumble LJ; Francis DM; Macdonald IM; Clunie GJ; Kincaid-Smith P
Transplant Proc; 1990 Oct; 22(5):2139-40. PubMed ID: 2145672
[No Abstract] [Full Text] [Related]
10. The relationship of immunological responsiveness to suppression of cellular responses by cyclosporine in vitro.
MacSween JM; Cohen AD; Eastwood SL; Fernandez LA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1202-4. PubMed ID: 2978876
[No Abstract] [Full Text] [Related]
11. Rapamycin suppresses in vitro immunoglobulin production by human lymphocytes.
Luo H; Chen H; Daloze P; Chang J; Wu J
Transplant Proc; 1991 Aug; 23(4):2236-8. PubMed ID: 1871858
[No Abstract] [Full Text] [Related]
12. The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites.
Hartman NR; Jardine I
Drug Metab Dispos; 1987; 15(5):661-4. PubMed ID: 2891483
[TBL] [Abstract][Full Text] [Related]
13. Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro.
Beck Y; Akiyama N
Transplant Proc; 1989 Jun; 21(3):3464-7. PubMed ID: 2472695
[No Abstract] [Full Text] [Related]
14. Heterogeneity of dialysis patient lymphocyte responses to cyclosporine.
Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Burdick JF
Transplant Proc; 1996 Aug; 28(4):2063-5. PubMed ID: 8769157
[No Abstract] [Full Text] [Related]
15. Preoperative identification of high-risk recipients of first kidney transplants by in vitro lymphocyte resistance to immunosuppressive agents.
Francis DM; Dumble LJ; Bowes LG; MacDonald IM; Kincaid-Smith P; Clunie GJ
Transplant Proc; 1991 Feb; 23(1 Pt 2):1323-4. PubMed ID: 1824896
[No Abstract] [Full Text] [Related]
16. Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
Fahr A; Hiestand P; Ryffel B
Transplant Proc; 1990 Jun; 22(3):1116-24. PubMed ID: 2140916
[No Abstract] [Full Text] [Related]
17. Involvement of cyclosporine metabolites in therapeutic monitoring and immunosuppression.
Rosano TG; Freed BM; Pell MA; Dybas MT; Lempert N
Transplant Proc; 1987 Feb; 19(1 Pt 2):1699-703. PubMed ID: 2950633
[No Abstract] [Full Text] [Related]
18. Cyclosporin A and G inhibition of cytokine production.
Szturm K; Jeffery JR; Rush DN; McKenna RM
Transplant Proc; 1989 Feb; 21(1 Pt 1):857. PubMed ID: 2705251
[No Abstract] [Full Text] [Related]
19. An in vitro comparison of the immunosuppressive potential of synthetic prostaglandin analogues.
Redgrave NG; Dumble LJ; Pollak R; Bowes LG; Ruwart MJ; Clunie GJ
Transplant Proc; 1991 Feb; 23(1 Pt 1):346-7. PubMed ID: 1824986
[No Abstract] [Full Text] [Related]
20. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
